These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37440097)

  • 1. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
    Matsui JK; Allen PK; Perlow HK; Johnson JM; Paulino AC; McAleer MF; Fouladi M; Grosshans DR; Ghia AJ; Li J; Zaky WT; Chintagumpala MM; Palmer JD; McGovern SL
    J Neurooncol; 2023 Jul; 163(3):717-726. PubMed ID: 37440097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade gliomas in children and adolescents: is there a role for reoperation?
    Silva da Costa MD; Camargo NC; Dastoli PA; Nicácio JM; Benevides Silva FA; Sucharski Figueiredo ML; Chen MJ; Cappellano AM; Saba da Silva N; Cavalheiro S
    J Neurosurg Pediatr; 2021 Feb; 27(2):160-169. PubMed ID: 33307529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of multidisciplinary management in pediatric low-grade gliomas.
    Oh KS; Hung J; Robertson PL; Garton HJ; Muraszko KM; Sandler HM; Hamstra DA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e481-8. PubMed ID: 21470783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-grade gliomas in children: single institutional experience in 198 cases.
    Garzón M; García-Fructuoso G; Suñol M; Mora J; Cruz O
    Childs Nerv Syst; 2015 Sep; 31(9):1447-59. PubMed ID: 26156776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of socioeconomic status on clinical outcomes of diffuse midline glioma and diffuse intrinsic pontine glioma.
    Lee JH; Holste KG; Bah MG; Franson AT; Garton HJL; Maher CO; Muraszko KM
    J Neurosurg Pediatr; 2024 Jun; 33(6):507-515. PubMed ID: 38489807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
    Dono A; Takayasu T; Ballester LY; Esquenazi Y
    J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma.
    McCrea HJ; Bander ED; Venn RA; Reiner AS; Iorgulescu JB; Puchi LA; Schaefer PM; Cederquist G; Greenfield JP
    Neurosurgery; 2015 Sep; 77(3):443-52; discussion 452-3. PubMed ID: 26083157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.
    Jung TY; Lee JY; Kim DS; Park HJ; Kim CY; Ra YS; Lee MJ; Kim SH; Baek HJ; Kim IH; Park KD; Kim SK
    J Neurooncol; 2015 Jan; 121(2):413-9. PubMed ID: 25366367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics and Prognostic Analysis of Glioma in Human Immunodeficiency Virus-Infected Patients.
    Wang T; Gao T; Niu X; Xing X; Yang Y; Liu Y; Mao Q
    World Neurosurg; 2018 Jun; 114():e218-e223. PubMed ID: 29524717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
    Chi AS; Tarapore RS; Hall MD; Shonka N; Gardner S; Umemura Y; Sumrall A; Khatib Z; Mueller S; Kline C; Zaky W; Khatua S; Weathers SP; Odia Y; Niazi TN; Daghistani D; Cherrick I; Korones D; Karajannis MA; Kong XT; Minturn J; Waanders A; Arillaga-Romany I; Batchelor T; Wen PY; Merdinger K; Schalop L; Stogniew M; Allen JE; Oster W; Mehta MP
    J Neurooncol; 2019 Oct; 145(1):97-105. PubMed ID: 31456142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study.
    Yahanda AT; Patel B; Shah AS; Cahill DP; Sutherland G; Honeycutt J; Jensen RL; Rich KM; Dowling JL; Limbrick DD; Dacey RG; Kim AH; Leuthardt EC; Dunn GP; Zipfel GJ; Leonard JR; Smyth MD; Shah MV; Abram SR; Evans J; Chicoine MR
    Neurosurgery; 2020 Dec; 88(1):63-73. PubMed ID: 32717067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
    Pachocki CJ; Hol EM
    J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
    Kim MM; Speers C; Li P; Schipper M; Junck L; Leung D; Orringer D; Heth J; Umemura Y; Spratt DE; Wahl DR; Cao Y; Lawrence TS; Tsien CI
    J Neurooncol; 2019 Jun; 143(2):313-319. PubMed ID: 30977058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors effective on survival of patients with glioblastoma: Anadolu Medical Center experience.
    Guden M; Ayata HB; Ceylan C; Kilic A; Engin K
    Indian J Cancer; 2016; 53(3):382-386. PubMed ID: 28244465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.
    Palmer JD; Siglin J; Yamoah K; Dan T; Champ CE; Bar-Ad V; Werner-Wasik M; Evans JJ; Kim L; Glass J; Farrell C; Andrews DW; Shi W
    J Neurooncol; 2015 Sep; 124(2):215-21. PubMed ID: 26024653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
    Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
    BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
    Dahlrot RH
    Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
    Koo T; Lim DH; Seol HJ; Dho YS; Kim IH; Chang JH; Lee J; Jung TY; Gwak HS; Cho KH; Hong CK; Lee IJ; Kim E; Kim JH; Hong YK; Jang HS; Kim CY; Kim IA; Kim SH; Kim YI; Kim EY; Kim WC; Hong S
    J Neurooncol; 2018 Nov; 140(2):445-455. PubMed ID: 30097825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.
    Chai RC; Yan H; An SY; Pang B; Chen HY; Mu QH; Zhang KN; Zhang YW; Liu YQ; Liu X; Zhao Z; Jiang T; Wang YZ; Jia WQ
    Brain Pathol; 2023 Jul; 33(4):e13153. PubMed ID: 36751054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological characteristics and prognosis of diffuse midline gliomas with histone H3K27M mutation: an analysis of 30 cases].
    Li HN; Shan CG; Fan CZ; Cheng LN; Wu SG; Liu MT; Jiang GY; Li Z
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):192-198. PubMed ID: 30831644
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.